BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18550570)

  • 1. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
    Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.
    Brendle A; Brandt A; Johansson R; Enquist K; Hallmans G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Feb; 45(3):435-42. PubMed ID: 19008095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer.
    Lei H; Hemminki K; Johansson R; Altieri A; Enquist K; Henriksson R; Lenner P; Försti A
    Breast Cancer Res Treat; 2008 May; 109(1):165-75. PubMed ID: 17616807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
    Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
    Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
    Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
    Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
    Azimzadeh P; Romani S; Mohebbi SR; Mahmoudi T; Vahedi M; Fatemi SR; Zali N; Zali MR
    Cancer Genet; 2012 Oct; 205(10):501-7. PubMed ID: 22939228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
    Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
    Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
    Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
    Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
    Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
    Jakubowska A; Jaworska K; Cybulski C; Janicka A; Szymańska-Pasternak J; Lener M; Narod SA; Lubiński J;
    Eur J Cancer; 2009 Mar; 45(5):837-42. PubMed ID: 19071013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms of microRNA-binding sites in integrin genes and gastric cancer in Chinese Han population.
    Song X; Zhong H; Zhou J; Hu X; Zhou Y; Ye Y; Lu X; Wang J; Ying B; Wang L
    Tumour Biol; 2015 Apr; 36(4):2785-92. PubMed ID: 25472585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.
    Kurokawa A; Nagata M; Kitamura N; Noman AA; Ohnishi M; Ohyama T; Kobayashi T; Shingaki S; Takagi R;
    Cancer; 2008 Mar; 112(6):1272-81. PubMed ID: 18224668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
    Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural selection on human microRNA binding sites inferred from SNP data.
    Chen K; Rajewsky N
    Nat Genet; 2006 Dec; 38(12):1452-6. PubMed ID: 17072316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.